Loading...
XJPX
4531
Market cap40mUSD
Dec 05, Last price  
292.00JPY
1D
-0.34%
1Q
5.42%
Jan 2017
14.96%
Name

Yuki Gosei Kogyo Co Ltd

Chart & Performance

D1W1MN
XJPX:4531 chart
P/E
7.02
P/S
0.42
EPS
41.57
Div Yield, %
2.74%
Shrs. gr., 5y
-0.16%
Rev. gr., 5y
7.14%
Revenues
15.13b
+16.98%
10,501,403,00010,411,013,0009,602,831,0009,322,316,0008,116,579,0008,609,017,0009,422,580,00010,005,178,00010,576,448,00010,396,051,00010,073,000,00010,272,000,00010,717,000,00011,091,000,00012,361,000,00012,839,000,00012,932,000,00015,128,000,000
Net income
896m
+15.46%
261,646,000-782,875,000-567,622,000-11,963,000207,735,000337,890,00053,504,000330,209,000350,746,000355,307,000125,000,000104,000,000-42,000,000288,000,000248,000,000556,000,000776,000,000896,000,000
CFO
2.14b
+452.32%
1,543,069,000956,097,000144,956,0001,996,218,000-386,449,0001,197,487,0001,769,209,0001,384,604,000590,572,000486,083,000687,000,000656,000,0001,420,000,000352,000,0001,787,000,000668,000,000388,000,0002,143,000,000
Dividend
Mar 30, 202610 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.
URL
https://www.yuki-gosei.co.jp/
IPO date
Oct 02, 1962
Employees
295
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT